These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 19366048)

  • 21. Interferon α Induces the Apoptosis of Cervical Cancer HeLa Cells by Activating both the Intrinsic Mitochondrial Pathway and Endoplasmic Reticulum Stress-Induced Pathway.
    Shi WY; Cao C; Liu L
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy in patients with local HPV infection and high-grade squamous intraepithelial lesion following uterine cervical conization.
    Kovachev SM
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):314-318. PubMed ID: 32429720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loop electrosurgical excision procedures for cervical dysplasia: experience in a community hospital.
    Krebs HB; Pastore L; Helmkamp BF
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):289-93; discussion 293-5. PubMed ID: 8362938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in the use of immunotherapy to treat uterine cervical cancer.
    De Lorenzo BH; Ramos Mde C; Michelin MA; Murta EF
    Tumori; 2009; 95(1):1-7. PubMed ID: 19366048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.
    Santin AD; Bellone S; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Curr Pharm Des; 2005; 11(27):3485-500. PubMed ID: 16248803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
    Valdespino-Gómez VM
    Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical Cancer Immunotherapy: Facts and Hopes.
    Ferrall L; Lin KY; Roden RBS; Hung CF; Wu TC
    Clin Cancer Res; 2021 Sep; 27(18):4953-4973. PubMed ID: 33888488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.
    Vici P; Pizzuti L; Mariani L; Zampa G; Santini D; Di Lauro L; Gamucci T; Natoli C; Marchetti P; Barba M; Maugeri-Saccà M; Sergi D; Tomao F; Vizza E; Di Filippo S; Paolini F; Curzio G; Corrado G; Michelotti A; Sanguineti G; Giordano A; De Maria R; Venuti A
    Expert Rev Vaccines; 2016 Oct; 15(10):1327-36. PubMed ID: 27063030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches in vaccine-based immunotherapy for human papillomavirus-induced cancer.
    van der Sluis TC; van der Burg SH; Arens R; Melief CJ
    Curr Opin Immunol; 2015 Aug; 35():9-14. PubMed ID: 26001120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in immunotherapy for cervical cancer.
    Wendel Naumann R; Leath CA
    Curr Opin Oncol; 2020 Sep; 32(5):481-487. PubMed ID: 32740092
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.